Global Alliance For Tb Drug Development Inc
New York, New York
Financial Health Score
9-metric score across financial health, operational efficiency, and organizational resilience. Based on IRS Form 990 data.
Very Good
How This Organization Compares
Compared to 5 peers in Medical Research with $10M-$100M revenue
Working Capital Ratio (net assets ÷ expenses)
Financial Trends
5-Year Trend Analysis
Financial Health Indicators
Filing History
13 filings on record| Year | Revenue | Expenses | Assets | |
|---|---|---|---|---|
| 2023 | $60,240,486↑7% | $55,378,579↓1% | $197,319,541↑12% | — |
| 2022 | $56,212,963↓4% | $55,785,890↓3% | $176,686,879↓6% | — |
| 2021 | $58,653,379↓4% | $57,430,605↓7% | $187,560,796↓2% | — |
| 2020 | $61,267,452↓65% | $61,720,389↓11% | $191,155,661↑1% | — |
| 2019 | $174,873,899↑176% | $69,535,079↑15% | $189,418,881↑152% | — |
| 2018 | $63,283,490↑9% | $60,315,645↑7% | $75,171,538↑3% | — |
| 2017 | $58,006,498↑9% | $56,120,604↑4% | $72,985,406↓12% | — |
| 2016 | $53,033,369↓13% | $54,033,661↓7% | $83,056,988↓21% | — |
| 2015 | $61,262,524↑33% | $57,842,666↑34% | $104,991,923↑21% | — |
| 2014 | $45,896,921 | $43,236,701↑7% | $87,024,911↑21% | — |
| 2013 | $46,117,957 | $40,579,516↓5% | $71,932,038↑24% | — |
| 2012 | $46,256,409↓1% | $42,645,054↑16% | $58,144,210↑13% | — |
| 2011 | $46,946,367 | $36,738,555 | $51,559,287 | — |
Frequently Asked Questions
What does Global Alliance For Tb Drug Development Inc do?▼
Global Alliance For Tb Drug Development Inc is a medical research nonprofit organization based in New York. It is classified under NTEE code H80 and is registered as a 501(c) tax-exempt organization with the IRS.
Is Global Alliance For Tb Drug Development Inc financially healthy?▼
Based on our 9-metric Financial Health Score model, Global Alliance For Tb Drug Development Inc has a score of 78/100 (Grade: A-). This score evaluates working capital, surplus consistency, debt ratio, revenue trends, program spending, fundraising efficiency, executive compensation, revenue diversification, and vulnerability indicators.
How much revenue does Global Alliance For Tb Drug Development Inc generate?▼
Global Alliance For Tb Drug Development Inc reports $63.7M in annual revenue and holds $204.3M in total assets, based on IRS filings.
Similar Organizations
Explore more organizations in the Medical Research category, or browse all nonprofits in New York.